32 results
HIV HAART Medications - Classification by Names and Mechanism - Updated 01/2021
 - NRTIs
 - NNRTIs
HIV HAART Medications ... - Classification ... serotavirus #HIV #AIDS ... #ART #Antiretroviral ... #Therapy #Pharmacology
** See updated 01/2021 version here- https://www.grepmed.com/images/6497 **

HIV HAART Medications - Grouped by Brand Names and
** HIV HAART Medications ... serotavirus #HIV #AIDS ... #ART #Antiretroviral ... #Therapy #Pharmacology ... #Classification
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
Pneumonia - Typhoid fever ... mechanical ventilation, ARDS ... InfectiousDiseases #Infections #Pharmacology ... #Management #Treatment ... #Indications
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Trypanosomiasis) in HIV-AIDS ... optimization of ART ... Trypanosomiasis #IDSA ... infections #HIVAIDS #pharmacology
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
Dermatitis - Topical Treatment ... After non-pharmacologic ... has a different level ... is the newest medication ... #Medications #Pharmacology
Hepatitis B - Treatment Indications
Treatment not indicated:
 • Immune tolerant state - HBe-Ag detectable, high HBV
Indications Treatment ... infection with severe liver ... mg/dL) or acute liver ... #Indications #management ... #hepatology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... Women with in HIV-AIDS ... HumanPapillomavirus #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Infections in HIV-AIDS ... in response to ART ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Candidiasis in HIV-AIDS ... Systemic antifungals are ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
other cause of ARDS ... : 33% • Treatment ... • Criteria - At ... : No • Treatment ... Transfusion #Reactions #hematology